Department of Orthopedics, Peking University Third Hospital, Beijing, China.
Engineering Research Center of Bone and Joint Precision Medicine, Ministry of Education, Beijing, China.
Orthop Surg. 2024 Nov;16(11):2714-2721. doi: 10.1111/os.14184. Epub 2024 Aug 9.
Tourniquet is applied in Total Knee Arthroplasty (TKA) to reduce intraoperative blood loss and improve view of surgical field. However, tourniquet use in TKA is still in dispute. Some researchers find that tourniquet may lead to extra side effects such as aggravated pain and limb swelling, while others consider that tourniquet has no significant adverse impact on clinical outcomes of TKA patients. This trial is conducted to evaluate tourniquet effect on TKA patients.
A prospective, single-blind, randomized controlled trail is adopted with a sample size of 130 knees from August 2020 to February 2023. Patients undergoing TKA are randomly allocated to tourniquet group and non-tourniquet group. Outcomes including quadriceps thickness and stiffness, operation time, total blood loss, intraoperative blood loss, postoperative blood loss, transfusion rate, thigh circumference, knee and thigh VAS, D-Dimer and CRP level, knee function score, patient satisfaction, and complications are evaluated in this trial. Student's t-test, Mann-Whitney U test, Pearson's chi-square test, and Fisher's exact test are used in this study.
No significant difference in demographic information and baseline outcomes were found (p > 0.05). Participants in the tourniquet group had significantly less total blood loss and intraoperative blood loss, more postoperative blood loss, and higher D-Dimer level on postoperative day 3 when compared with non-tourniquet group (p < 0.05). Other outcomes including quadriceps thickness and stiffness, operation time, postoperative blood loss, transfusion rate, thigh circumference, knee and thigh VAS, D-Dimer level on postoperative day 1, CRP level, knee function score, patient satisfaction, and complications showed no significant difference (p > 0.05).
Tourniquet application can effectively reduce intraoperative blood loss and total blood loss, without significant side effects. Hence, we advocate the regular use of tourniquet in primary TKA.
止血带在全膝关节置换术(TKA)中应用,以减少术中失血量并改善手术视野。然而,TKA 中使用止血带仍存在争议。一些研究人员发现,止血带可能会导致额外的副作用,如加重疼痛和肢体肿胀,而另一些人则认为止血带对 TKA 患者的临床结果没有显著的不良影响。本试验旨在评估止血带对 TKA 患者的影响。
采用前瞻性、单盲、随机对照试验,2020 年 8 月至 2023 年 2 月共纳入 130 例膝关节。将接受 TKA 的患者随机分为止血带组和非止血带组。评估两组患者的股四头肌厚度和僵硬、手术时间、总失血量、术中失血量、术后失血量、输血率、大腿周径、膝关节和大腿 VAS、D-二聚体和 CRP 水平、膝关节功能评分、患者满意度和并发症等。本研究采用 Student's t 检验、Mann-Whitney U 检验、Pearson 卡方检验和 Fisher 确切检验。
两组患者的人口统计学信息和基线结果无显著差异(p>0.05)。与非止血带组相比,止血带组患者的总失血量和术中失血量明显减少,术后失血量较多,术后第 3 天 D-二聚体水平较高(p<0.05)。两组患者的股四头肌厚度和僵硬、手术时间、术后失血量、输血率、大腿周径、膝关节和大腿 VAS、术后第 1 天 D-二聚体水平、CRP 水平、膝关节功能评分、患者满意度和并发症无显著差异(p>0.05)。
止血带的应用可以有效减少术中失血量和总失血量,且无明显副作用。因此,我们主张在初次 TKA 中常规使用止血带。